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Abstract Lipocalins form a large multifunctional family of
small proteins (15^25 kDa) ¢rst discovered in eukaryotes.
More recently, several types of bacterial lipocalins have been
reported, among which Blc from Escherichia coli is an outer
membrane lipoprotein. As part of our structural genomics e¡ort
on proteins from E. coli, we have expressed, crystallized and
solved the structure of Blc at 1.8 A) resolution using remote
SAD with xenon. The structure of Blc, the ¢rst of a bacterial
lipocalin, exhibits a classical fold formed by a L-barrel and a
K-helix similar to that of the moth bilin binding protein. Its
empty and open cavity, however, is too narrow to accommodate
bilin, while the alkyl chains of two fatty acids or of a phospho-
lipid could be readily modeled inside the cavity. Blc was re-
ported to be expressed under stress conditions such as starvation
or high osmolarity, during which the cell envelope su¡ers and
requires maintenance. These data, together with our structural
interpretation, suggest a role for Blc in storage or transport of
lipids necessary for membrane repair or maintenance.
/ 2004 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
Key words: Lipocalin; Blc; Xenon; Remote SAD;
Structural genomics; Lipid transport
1. Introduction
Lipocalins pertain to a large family of proteins which was
identi¢ed initially in eukaryotes [1] and more recently in
Gram-negative bacteria [2,3]. Lipocalins are considered to
be lipophilic carriers (hence their name), but their functions
(often putative) have been reported as very diverse [3,4] (see
also papers in Biochim. Biophys. Acta Vol. 1482). Only a few
lipocalins have a well de¢ned and studied function. Among
them, the retinol binding protein was the ¢rst whose three-
dimensional structure has been solved [5]. Other lipocalins
have been proposed to carry pheromones [6^8] or odorant
molecules [9,10]. Outlier members of the lipocalin family,
identi¢ed in the salivary gland of ticks, sequester histamine
produced by the host [11]. Recently, the iron binding function
of siderocalins, a new class of lipocalins, has been assigned by
virtue of the crystal structure [12].
The lipocalin fold is very well conserved: it features an
eight-stranded L-barrel and a C-terminal domain with an
K-helix [13]. Decorations, such as an extra strand, may com-
plete the structure. The number of disul¢de bridges can vary
from one to three in mammalian lipocalins, with the exception
of bovine odorant binding protein which does not possess
cysteines and forms a peculiar domain-swapped dimer [10].
The amino acid sequences of lipocalins, however, are very
poorly conserved, and only a few signatures have been de-
scribed, among which the most general is at the N-terminus
and consists of a GXW motif [1,13]. Sequence comparisons
and evolution analysis of lipocalins have led to a classi¢cation
in which V14 clades have been identi¢ed [14]. Clade 1 (the
root clade) includes mainly bacterial lipocalins, clade 2 those
from insects, whereas other eukaryotic and mammalian lipo-
calins are found in the higher clades (3^14).
Most bacterial lipocalins are lipoproteins which contain a
type 2 signal peptide allowing export to the periplasm [2,3]. In
the larger of the two identi¢ed groups, one or two cysteines
are observed and no disul¢de bridge is found. The ¢rst cys-
teine, located just after the signal peptide, is attached to the
membrane anchor lipid forming a N-acyl-S-sn-1,2-diacylgly-
cerylcysteine moiety at the N-terminus [2,3]. A smaller sub-
group of bacterial lipocalins contains a disul¢de bridge and its
members have diverse predicted localizations in the cyto-
plasm, periplasm and the inner and outer membranes [2,3].
The paradigm for bacterial lipocalins is provided by the blc
gene from Escherichia coli, the ¢rst bacterial lipocalin that has
been identi¢ed [2]. Blc is an outer membrane bound protein,
facing the periplasmic space. It is expressed during the steady
phase, under stress conditions such as starvation or high os-
molarity, during which the cell envelope su¡ers and requires
maintenance [3]. A putative function of Blc might therefore be
to store or carry lipids. Interestingly, the two close sequence
neighbors of Blc in insects or mammals, namely Lazarillo [15]
and ApoD [16], are believed to interact with lipids (Fig. 1A).
It has been proposed that ApoD may participate in mainte-
nance and repair in the central and peripheral nervous sys-
tems. ApoD could transport a ligand from one cell to another
within an organ, scavenge a ligand within an organ for trans-
port to the blood or could transport a ligand from the blood
to speci¢c cells within a tissue [17].
The three-dimensional structure of eukaryotic lipocalins is
well documented for members of clades 2^14, but no structure
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of a true bacterial lipocalin was available. Recently, however,
E. coli YodA protein was shown to possess a domain with a
L-barrel fold resembling that of lipocalins [18]. In the course
of a structural genomics program dealing with bacterial pro-
teins, we have expressed, crystallized and characterized Blc.
Its structure, solved by remote SAD methods with xenon
[19,20], has been re¢ned to 1.8 AN resolution. It reveals a
fold similar to that of the moth bilin binding protein (BBP)
[21] as expected from the 22% sequence identity between the
two proteins (Fig. 1B). The elongated and open cavity present
in Blc is narrower than the cavity of BBP. In consequence,
large ligands such as bilins or hemes do not ¢t the cavity.
Instead, the cavity could bind two fatty acid chains placed
side to side.
2. Materials and methods
2.1. Expression and puri¢cation
Subcloning and expression strategies used for our E. coli targets,
including the blc gene, have already been described elsewhere [22,23].
The blc gene segment designed for this study was almost complete,
starting three residues after the cysteine residue used to anchor Blc to
the membrane, thus yielding a putative soluble, well behaving protein.
This shorter blc gene segment was ampli¢ed by polymerase chain
reaction from E. coli K12 genomic DNA and was subcloned in the
pDest17 vector by recombination [24] using the Gateway1 technology
(Invitrogen). Expression was carried out using the Tuner(DE3)pLysS
E. coli strain. The protein was soluble and was puri¢ed on a nickel
column followed by gel ¢ltration on a Superdex 200 column in
HEPES 5 mM, NaCl 150 mM, pH 7.5.
2.2. Crystallization
Crystals of the protein were grown at 20‡C using sitting drops and
the nanodrop technology [23] followed by optimization [25]. A volume
of 100 nl of a protein solution at 6^8 mg/ml in HEPES 5 mM, NaCl
150 mM, pH 7.5, was mixed with 100 nl of precipitant solution con-
sisting of sodium citrate 800^900 mM, sodium borate 50 mM, pH
7.0^7.5. Crystals grew within 1^3 days and proved to belong to the
orthorhombic space group P212121 (a=58.0 AN , b=80.8 AN , c=89.0 AN )
with two molecules per asymmetric unit (Vm=2.6 AN 3/Da; 59% sol-
vent).
2.3. Data collection and processing
A native crystal was transferred into a cryo-solution made of the
crystallization bu¡er supplemented with 25% glycerol and pressurized
at 25 bar with xenon for 5 min using the Oxford Cryosystems XCell.
Xenon-derivatized data were collected on a single £ash-cooled crystal
on beamline ID14-EH4 at the European Synchrotron Radiation Fa-
cility (ESRF) in Grenoble (France) using an ADSC Quantum 4 CCD
detector. A total of 553 images were collected using a 1‡ oscillation
range per image at 1.0332 AN wavelength. The native data were also
collected on beamline ID14-EH4 at 0.9393 AN wavelength. Both data
sets were processed with MOSFLM and scaling was performed using
SCALA from the CCP4 [26] suite (Table 1).
2.4. Structure solution
Xenon positions were determined using SHELXD [27] with data in
the resolution range from 20 AN to 2.3 AN . Two sites were found.
Position re¢nement, phase calculation and density modi¢cation were
performed using SHARP [28]. Phase extension using the isomorphous
native data set was performed with DM [29]. ARP-wARP [30] version
6.0 integrated in CCP4i was run to build automatically the two mol-
ecules in the asymmetric unit. This ¢nal solution was assigned to its
sequence using the X-Auto¢t option in Quanta (Accelerys, San Diego,
CA, USA) and re¢ned using REFMAC [31].
Fig. 1. A: Sequence alignment of Blc with human ApoD and Schistocerca americana Lazarillo. Identical residues are in white on a red back-
ground. The attb1 sequence at the N-terminus of the expressed protein is (Blc-X) boxed in green, and the hydrophobic loop of ApoD is boxed
in light blue. The cysteines of ApoD and Lazarillo forming two disul¢de bridges are identi¢ed by green and blue dots. The peptides cleaved at
the N- and C-termini (leading to the mature proteins) are boxed in yellow. B: Sequence alignment of Blc with BBP [21].
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3. Results and discussion
3.1. Structure solution and xenon site
Although Blc shares 25% identity with BBP (Fig. 1B), its
structure could not be solved by molecular replacement using
AMoRe and the structure of BBP as a starting model. Since
lipocalins are known to harbor a hydrophobic cavity, we de-
cided to try high pressure soaking with xenon. Xenon has
been frequently and successfully used as a MIR/SIR derivative
[19] but not as an anomalous scatterer due to the high Xe L1
absorption edge (2.27 AN ). We decided however to try a remote
SAD approach and collected data at 1.03 AN resolution, pro-
viding 3.5 anomalous electrons. Such an approach has been
described recently [20]. The structure could be readily solved
(see Section 2) and the maps reveal the presence of a unique
well ordered xenon per molecule, in a hydrophobic environ-
ment formed by Tyr 39, Tyr 64, Leu 72, Ala 93, Val 106 and
Tyr 116, in a small pocket adjacent to the main cavity (Fig. 2).
3.2. The overall structure
The Blc structure has a typical lipocalin fold consisting of a
L-barrel with eight antiparallel strands (strands 2^9, Fig. 3)
and an K-helix at the C-terminus. An extra L-strand (strand 1,
Fig. 3) does not belong to the L-barrel and weakly contacts
strand 7 in a quasi-parallel fashion. A stretch of 13 residues,
originating from the attb1 Gateway pDest17 vector recombi-
nation sequence [24], and a histidine from the 6UHis tag,
form an extended structure with a L-strand at its center
(strand 31, Fig. 3), antiparallel to strand 1, and located op-
posite to the L-barrel open cavity.
Besides the N-terminal cysteine, which allows Blc to bind to
the membrane through a lipid anchor, the single Cys 131 is
buried 9 AN below the protein surface in a tight and hydro-
phobic environment: Pro 24, Asn 117 CL, Leu 119 and Phe
164. No particular function can be easily assigned to this res-
idue. In the two eukaryotic lipocalins similar to Blc, Lazarillo
and ApoD, the equivalent cysteine forms a disul¢de bridge
with another cysteine at the N-terminus (Fig. 1). Attachment
to the membrane involves a GPI anchor in the case of Laza-
rillo [15] and binding of human ApoD [17] to ApoAII is
performed through a disul¢de bridge (see below) (Fig. 1) [3].
Table 1
Blc data collection and re¢nement
Data collection Native
Detector type ADSC Quantum 4R CCD
Radiation source ESRF (ID14-EH4)
Wavelength (AN ) 0.9393
Temperature (K) 100
Space group P212121
Cell (AN ) a=58.0, b=80.8, c=88.95
Resolution (AN )a 47.0^1.75 (1.84^1.75)
Completenessa (%) 98.1 (92.8)
Rsym a (%) 9.7 (36.9)
Multiplicity/I/cIa 5.4 (2.7)/14.5 (1.8)
Re¢nement
Resolution (AN ) 47.0^1.75
Unique re£ections 41 968
No. residues/water 333/306
R/Rfree 0.169/0.204
Mean B value (AN 2) 19.9
aValues in parentheses are for the highest resolution shell (1.84^
1.75 AN ).
Fig. 2. Stereo view of the xenon binding site of Blc. The Fo3Fc electron density map is contoured at threshold levels of 5 and 8 c (picture
made with Turbo-Frodo [34]).
Fig. 3. Ribbon view of Blc, rainbow colored from N-terminus (blue)
to C-terminus (red). The L-strands are numbered 1^9, plus the extra
strand at the N-terminus (31). The extra 12 residues at the N-ter-
minus, from the attb1 sequence, are localized between the NtP and
Nt labels. Blc itself starts at the red dot level (Nt) (picture made
with PyMOL [35]).
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When superimposing Blc to its closest three-dimensional
neighbor, BBP [21], a rmsd value of 2.2 AN (on 160 CK atoms)
is obtained. Deviations occur at the helix, which is tilted dif-
ferently, in the loops and along some strands (Fig. 4): strand
104^115, forming part of the wall of the cavity, has a position
completely di¡erent in Blc and BBP. Strands 8 and 9, £anking
the loop 132^137 in Blc, are much longer in BBP and form an
extended structure of eight residues (Fig. 4). The loop between
these strands is hydrophobic in ApoD, and has been postu-
lated to mediate the interaction with HDL. It has been shown
that a Cys residue at the beginning of the loop in human
ApoD forms a disul¢de bridge with ApoAII associated with
HDL (Fig. 1) [3]. This cysteine does not exist in ApoDs from
other species, and the hydrophobic loop anchors ApoD to the
membrane.
In addition to the extra attb1 segment, Blc L-strand 1 also
interacts with strand 7 and follows the same path as an ex-
tended structure in BBP. The most striking di¡erence between
the two lipocalins is in the N-terminus, which isV10 residues
longer in BBP than in Blc. At the very end of BBP, the N-
terminal L-strand 1 interacts in an antiparallel manner with
strand 9 and extends the size of the open cavity of BBP.
3.3. The cavity and its putative ligands
The calyx of Blc forms an open cavity V18 AN deep by
12U7 AN . The cavity opening is located opposite to the real
N-terminus of Blc (Fig. 3), the site of membrane attachment,
Fig. 4. Superimposed ribbon view of Blc (blue) and BBP (magenta).
Some strands, discussed in the text, have been numbered (picture
made with PyMOL [35]).
Fig. 5. Molecular surface of Blc cut at the level of the cavity. The L-strands are rainbow colored from the N-terminus (blue) to the C-terminus
(red). A: View parallel to the L-barrel axis. B: View perpendicular to the L-barrel axis. C: A model of the bilin from the BBP structure [21]
bound in the internal crevice. Note that only half of the bilin can ¢t in the cavity. D: A model with two fatty acids bound in the cavity. The
alkyl chains ¢t the cavity walls well, indicating that ligands such as fatty acids or phospholipids might be transported or stored by Blc (pictures
made with PyMOL [35]).
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and thus faces the bulk periplasmic £uid. Adjacent to this
main cavity, a smaller one forms the xenon binding site
(Fig. 5A,B). The main cavity is less opened and narrower
than the BBP calyx. After structural superimposition, bilin,
the ligand of BBP [21], could not be ¢tted in the Blc cavity
because of a large number of steric clashes with the Blc core
(Fig. 5C).
In contrast with the cavity walls of retinol binding protein
[5] or odorant binding protein [10], which are formed almost
exclusively of hydrophobic residues, those of Blc are formed
by hydrophobic, semi-polar and charged residues. The largest
part is that of aromatic and aliphatic residues: Phe 53, Leu
57, Ala 62, Tyr 64, Val 74, Val 106, Phe 108, Tyr 116, Val
130, Trp 139 and Leu 141. In addition, two polar non-charged
residues complete the wall, Asn 67 and Ser 89. These two
residues protrude in the cavity. More surprisingly, two
charged residues line the cavity wall, Glu 45 and Glu 54. Their
carboxylic groups are in close contact (2.46 AN ), which indi-
cates that one of them is protonated. Glu 45 establishes an
ionic bond with Arg 46, while Glu 54 is hydrogen-bonded to
His 51. The two glutamic acids and the arginine are conserved
in the sequence of BBP [21] and are in structurally equivalent
positions compared to Blc.
Residues pertaining to the three classes, hydrophobic, semi-
polar and polar, form the mouth of the cavity. Both positively
and negatively charged residues are found: two negatively
charged residues, Asp 82 and Glu 90, and four positively
charged residues, arginines 52, 55 and 83, and Lys 92. The
latter residues would be well suited for interacting with the
phosphate moiety of a loaded phospholipid. Alternatively,
they might also interact with phospholipids from the outer
membrane.
As mentioned before, the binding cavity of Blc is long, £at
and relatively narrow (Fig. 5A,B). It is not large enough to
accommodate molecules such as bilins (Fig. 5C) or hemes, but
it has a size su⁄cient to accommodate elongated chains or
linear polycyclic structures such as anthracene derivatives. We
have easily modeled two side-to-side fatty acids in the cavity
(Fig. 5D). With an alkyl chain length of 14 carbons, both
carboxylate moieties emerge in the solvent, near the Blc sur-
face. Similarly, the two fatty acid chains of a phospholipid
could ¢t the cavity, and its phosphate could interact with the
positively charged residues around the cavity entrance, thus
enhancing the binding a⁄nity.
4. Conclusion and functional clues
Blc is a membrane-bound protein expressed in stress con-
ditions which a¡ect the membrane. The cavity of Blc is capa-
ble of binding up to two fatty acids. Other lipocalins such as
cellular fatty acid binding proteins (FABP) [32] are lipocalins
involved in fatty acid transport for membrane maintenance in,
for example, heart and skeletal muscles [33]. A unique char-
acteristic of Blc compared to FABPs, however, is its attach-
ment to the outer membrane. This prevents Blc from traveling
freely through the periplasmic space. However, Blc could still
move laterally along the outer membrane and thus be capable
of lipid transport. Such a two-dimensional di¡usion may be
more e⁄cient and fast than free di¡usion in the periplasm.
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